Kezar Life Sciences, Inc. Common Stock

KZR US49372L1008

💰
Capitalization
Small-cap

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
3
🙍
Insiders
2
Person Price Shares Total Published Completed
Schiller Mark C.
COO
4.28
USD
561
Sold
2,401
USD
02/07/2025 02/07/2025
Chiang Pichi Luo
VP
4.28
USD
264
Sold
1,130
USD
02/07/2025 02/07/2025
Schiller Mark C.
CLO
0.58
USD
6,688
Sold
3,879
USD
02/07/2024 02/07/2024
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Kezar Life Sciences, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Schiller Mark C. 2 6,280.12 3,140.06 02/07/2024 02/07/2025
Chiang Pichi Luo 1 1,129.92 1,129.92 02/07/2025 02/07/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.